Patents
Patents for C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
09/2005
09/07/2005EP1569931A1 Heterocyclic compounds as ccr5 antagonists
09/07/2005EP1569647A2 Cyclohexyl compounds as ccr5 antagonists
09/07/2005EP1569646A2 Piperidine derivatives as ccr5 antagonists
09/07/2005EP1569644A2 Indolizine compounds
09/07/2005CN1665789A Diaminopyrimidinecarboxa mide derivative
09/07/2005CN1665785A 2-cyano-4-fluoropyrrolidine derivative or its salt
09/07/2005CN1217943C New use and novel N-azabicyclo-amide derivatives
09/01/2005WO2005080389A1 Indazole-carboxamide compounds as 5-ht4 receptor agonists
09/01/2005WO2005070133A3 2,6-disubstituted piperidines as modulators of chemokine receptor activity
09/01/2005WO2005046586A8 M3 muscarinic acetylcholine receptor antagonists
09/01/2005WO2005042533A3 2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-iv inhibitors
09/01/2005US20050192430 For use as fluorescent labels with central nervous system drugs
09/01/2005DE102004004965A1 Verbessertes Verfahren zur Herstellung eines 2-(Ethoxymethyl)-tropanderivates An improved process for the preparation of a 2- (ethoxymethyl) -tropanderivates
09/01/2005CA2553696A1 Indazole-carboxamide compounds as 5-ht4 receptor agonists
08/2005
08/31/2005EP1567526A1 Carbamic acid esters with an anticholinergic action
08/31/2005CN1662530A Azabicyclo-octane and nonane derivatives with DPP-IV inhibiting activity
08/30/2005US6936600 Oxidoreductase enzyme inhibitors such as (R)-1-[4-(2-methyl-4-phenyl-5,8-dihydro-6H-pyrido[3,4-d]pyrimidin-7-yl)-pyrimidin-2-yl-ethanol, used as antidiabetic agents
08/25/2005WO2005077932A2 Chemokine receptor antagonists
08/25/2005WO2005077899A2 Amino-substituted tricyclic derivatives and methods of use
08/25/2005CA2555884A1 Amino-substituted tricyclic derivatives and methods of use
08/24/2005EP1565192A2 Method and compositions for temporarily incapaciting subjets
08/24/2005EP1565178A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
08/24/2005EP1497289B1 Medicaments containing betamimetic drugs and a novel anticholinesterase drug
08/18/2005WO2005075472A1 3-(diheteroarylnethylene)-8-azabicyclo[3.2.1]octane and 3-(aryl)(heteroaryl)methylene)-8-azabicyclo[3.2.1]octane derivatives
08/18/2005US20050182088 Modulate neurotransmission by promoting the release of neurotransmitters such as acetylcholine, dopamine and norepinephrine; thio-bridged aryl derivatives; treats central and autonomic nervous system disorders
08/18/2005US20050182040 Benzamide derivatives
08/17/2005CN1655787A Triple monoamine reuptake inhibitors for the treatment of chronic pain
08/17/2005CN1655779A Substituted benzazoles and methods of their use as inhibitors of Raf kinase
08/16/2005US6930107 treating obesity, overweight condition, hyperlipidemia, thyroid disease, hypothyroidism, thyroid cancer and related disorders
08/11/2005WO2005073228A1 Method for producing a 2-(ethoxymethyl)tropane derivative
08/11/2005WO2005036961A3 N-substituted azacycles
08/11/2005US20050176771 4-fluoro-1-({[1-(methanesulfonyl)piperidin-4-yl]amino}acetyl)pyrrolidine-2-carbonitrile; insulin-dependent diabetes (type 1 diabetes), non insulin-dependent diabetes (type 2 diabetes), insulin-resistant disorders, obesity; dipeptidyl peptidase IV-inhibiting activity
08/11/2005US20050176757 For example, 6-[4-(4-Amino-5-chloro-2-methoxy-benzoylamino)-3-methoxy-piperidin-1-yl]-hexanoic acid 1-aza-bicyclo[2.2.2]oct-3-yl ester; for treatment of gastrointestinal disorders including gastroparesis, gastroesophageal reflux
08/11/2005US20050176755 Aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists
08/11/2005CA2554125A1 Method for producing a 2-(ethoxymethyl)tropane derivative
08/10/2005EP1561751A1 Fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals
08/10/2005CN1652782A Nicotinamide derivatives useful as PDE4 inhibitors
08/04/2005WO2005070133A2 2,6-disubstituted piperidines as modulators of chemokine receptor activity
08/04/2005WO2005054244A3 Azabicyclooctene and other tetrahydropyridine derivatives with a new side-chain
08/04/2005WO2005030188A3 Phenyl-piperazine derivatives as modulators of muscarinic receptors
08/04/2005US20050171353 Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially ccr5)
08/04/2005US20050171145 Process for the preparation of 2-(ethoxymethyl)-tropane derivatives
08/04/2005US20050171099 Delta and mu opioid receptors modulators, agonist or antagonist; analgesics, immunosuppressants, antiinflammatory agents; 3-(Phenyl-thiophen-3-yl-methylene)-8-aza-bicyclo[3.2.1]octane; ; neurological and psychiatric conditions; drug and alcohol abuse,; gastritis; diarrhea; cardiovascular; respiratory
08/04/2005US20050171079 2,7-bis-[(3R)-1-azabicyclo[2.2.2]octan-3-yloxy]-fluoren-9-one; 2,7-bis[(2R)-azetidin-2-ylmethoxy]-fluoren-9-one; alpha 7 Nicotinic acetylcholine receptors ligands; cognitive disorder, neurodegeneration, and neurodevelopmental disorders
08/04/2005US20050171078 Cholinergic ligands at the nicotinic acetylcholine receptors; diseases related to the cholinergic system; neurodegenerative disorders; pain; antiinflammatory; diagnostic or monitoring tools using labelled forms; 3-Phenyletynyl-quinuclidin-2-ene
08/04/2005CA2553242A1 2,6-disubstituted piperidines as modulators of chemokine receptor activity
08/03/2005EP1558600A1 Selected cgrp antagonists, method for production and use thereof as medicament
08/03/2005CN1649884A Novel azacyclic ethynyl derivatives
08/03/2005CN1649853A Thiazolidinones compound, its preparing method and use as medicine
07/2005
07/28/2005WO2005068461A1 Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
07/28/2005WO2005067537A2 Muscarinic acetylcholine receptor antagonists
07/28/2005WO2005046586A3 M3 muscarinic acetylcholine receptor antagonists
07/28/2005CA2552880A1 Muscarinic acetylcholine receptor antagonists
07/27/2005CN1646527A Medicaments containing BETAMIMETICS drugs and a novel anticholinesterase drug
07/27/2005CN1646526A Tropane derivatives as CCR5 modulators
07/27/2005CN1646126A Medicaments containing steroids and a novel anticholinesterase drug
07/27/2005CN1646095A Inhalation kit comprisung inhalable powder of tiotropium
07/26/2005US6921821 Antagonists of melanin concentrating hormone receptor
07/21/2005US20050159436 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof
07/20/2005EP1472251B1 Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals
07/20/2005EP1272484B1 Benzoamide piperidine compounds as substance p antagonists
07/20/2005CN1642952A Micronized crystalline tiotropium bromide
07/20/2005CN1642913A Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially CCR5)
07/14/2005US20050154023 1-(4-methoxynaphthalene-1-sulfonyl)-2,3-dihydro-1H-indole-3-carboxylic acid [2-(1-methyl-pyrrolidin-2-yl)-ethyl]amide; selective affinity for 5-HT6 receptor; psychosis, schizophrenia, depression, neurological disorders, cognitive enhancement, Parkinson's disease, ALS, Alzheimer's, Huntington's disease
07/14/2005US20050153973 (4R)-3-(2-{[8-(2-Pyrimidinyl)-8-azabicyclo[3.2.1]oct-3-yl]exo-amino}acetyl)thiazolidine-4-carbonitrile; enzyme inhibitors; diabetes
07/13/2005EP1551832A1 8-azabicyclo[3.2.1]octane ether derivatives and their use as neurokinin receptor antagonists
07/13/2005EP1551829A2 Novel compounds with antibacterial activity
07/13/2005CN1639159A N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as DDP-IV inhibitors
07/13/2005CN1639152A Pyrrole-2, 5-dione derivatives and their use as GSK-3 inhibitors
07/13/2005CN1638633A Agonists and antagonists of 5h3-like receptors of invertebrates as pesticides
07/13/2005CN1210265C Phthalazine derivatives and remedies for erectile dysfunction
07/13/2005CN1210017C Novel tiotropiumonium-containing inhalation powder
07/07/2005US20050148623 HIV protease inhibiting compounds
07/07/2005US20050148573 Benzimidazolone compounds having 5-HT4 receptor agonistic activity
07/06/2005CN1635891A Tetrahydroquinoline analogues as muscarinic agonists
07/06/2005CN1635877A Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
06/2005
06/30/2005WO2005058881A1 Chemical compounds
06/30/2005WO2005058317A1 Glycine transporter-1 inhibirors
06/30/2005US20050143410 Of tiotropium bromide; chronic obstructive pulmonary disease (COPD) and asthma; storage stability, only limited hygroscopic characteristics
06/30/2005US20050143373 Benzodioxole derivatives
06/29/2005EP1545532A2 Heterocyclic compounds
06/29/2005CN1633297A Acylated piperidine derivatives as melanocortin-4 receptor agonists
06/23/2005WO2005037224A3 Muscarinic acetylcholine receptor antagonists
06/23/2005US20050137224 2-Cyanopyrrolidinecarboxamide compound
06/23/2005US20050137211 Phenyl-piperazine derivatives as modulators of muscarinic receptors
06/22/2005EP1233964B1 New use and novel n-azabicyclo-amide derivatives
06/21/2005US6908928 Anticholinergic agent
06/21/2005CA2250372C 6-phenylpyridyl-2-amine derivatives
06/16/2005WO2005054244A2 Azabicyclooctene and other tetrahydropyridine derivatives with a new side-chain
06/16/2005US20050131007 Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof
06/16/2005US20050130981 Compounds
06/16/2005CA2547551A1 Diazabicyclononene and tetrahydropyridine derivatives with a new side-chain
06/15/2005EP1541551A1 2-cyano-4-fluoropyrrolidine derivative or its salt
06/09/2005WO2005051948A1 Radioactive tropane alkaloid derivative, tropane alkaloid derivative, and process for producing them
06/09/2005WO2005051390A1 E-fluoro-4-(pyridin-2-yl)-piperidine-1-carboxamide derivatives and related compounds which modulate the function of the vanilloid-1 receptor (vr1) for the treatment of pain
06/09/2005US20050124813 Industrial process for preparing tropenol
06/09/2005US20050124607 5-Substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists
06/08/2005CN1625557A Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
06/08/2005CN1625556A Anticholinergics, processes for the preparation thereof, and pharmaceutical compositions
06/08/2005CN1205211C Pleuromutilin derivatives as antimicrobials
1 ... 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 ... 53